Be the new Senior Analytical Scientist
In a biotech company bonding to discover, design and develop innovative peptide-based medicines.
We are actively seeking an accomplished Senior Analytical Scientist who thrives in a collaborative and inclusive environment, excels in handling complex tasks, and enjoys continuous learning. If this sounds like you, and you are ready to embrace a broad range of responsibilities with an independent mindset, then you are the perfect fit for us.
Your responsibilities will include late-stage analytical development with a broad range of activities in development projects. Given our collaboration with Contract Manufacturing Organizations (CMO), effective coordination with external partners is a significant aspect of this role.
You will be joining a highly experienced team consisting of experts within CMC Development. We value a friendly, helpful, and fun atmosphere where we obtain ambitious results together.
Responsibilities
- Overall responsibility for analytical late-stage development activities, including all relevant analytical methods, especially HPLC and SEC
- Support development projects with analytical knowledge and activities such as stability programs, specifications, extractable/leachable studies, characterizations etc.
- Manage the collaboration with CDMO (follow-up on plans and day-to-day communication, securing transfer and validation of methods and supporting technical and QC activities)
- Write scientific reports and documentation meeting the requirements for pharmaceutical products, including regulatory documents (CTA/IMPD and NDA/MAA)
- Actively contribute to the CMC team, working collaboratively on project progress towards regulatory approval
Candidate profile
- A M.Sc/PhD within chemistry, biochemistry or pharmaceutical sciences
- Minimum of 5 years' experience in the Pharmaceutical Industry within analytical science or QC. Experience with HPLC methods of peptide-based products is preferred
- Experience with GMP and regulatory aspects of late-stage analytical CMC development
- Experience with outsourcing to CDMO and Contract labs
- Well-developed collaboration skills and excel in coordinating activities within and across projects
- The ability and engagement to “walk the extra mile” and taking on new challenges
- Friendly mindset and great people and stakeholder management skills
Bonding to innovate
Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.
Making bonds is at the core of everything we do. From discovering and developing the best new peptide drugs for patients, to engaging with our partners or connecting with each other.
We bond as a result of our entrepreneurial culture where our people are encouraged to pursue their ideas and turn them into reality. We are curious about each other’s knowledge and expertise.
We bond through curiosity and playfulness as a team, allowing ourselves to challenge common thinking and drive future innovation. Zealand Pharma is a place where everyone is heard and contributes to the success, we all want to experience.
The Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.
Let’s bond and be bold
We offer a combined compensation package which includes a base salary, pension, bonus, and a possibility to join our employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities
To find out more about working at Zealand, visit https://www.zealandpharma.com/careers/zealand-as-a-workplace/
Interested? Please apply no later than 31 August 2025, or as soon as possible. The applications will be reviewed as they come in.
For further information, please contact Britt Gren Sjøholm before 15 August 2025 at BSjoholm@zealandpharma.com
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand Pharma’s business and activities, please visit www.zealandpharma.com.
